Vionelix Pharmaceuticals
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
555 Fayetteville St Ste 201, Raleigh, No...Phone Number
(919) 944-4229Website
www.vionelix.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Vionelix Pharmaceuticals
Vionelix Pharmaceuticals, Inc. is an early-stage Anglo-American biotech company focused on revolutionizing antiviral therapies through its proprietary RAPTOR-AI platform. The company develops direct-acting antiviral drugs designed to be effective against treatment-resistant infections and rapidly mutating pathogens, targeting diseases such as hepatitis B, influenza, and smallpox. Their innovative approach allows for rapid drug development that circumvents viral mutations, making their treatments suitable for post-exposure prophylaxis. Vionelix aims to address the global challenge of viral infections and the loss of vaccine efficacy due to rapid mutations.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vionelix Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Vionelix Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Vionelix Pharmaceuticals
Product Launch: Get notified when Vionelix Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Vionelix Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Vionelix Pharmaceuticals recently announced quarterly report
Vionelix Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Vionelix Pharmaceuticals is spiking on competitors!
Check if Vionelix Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Vionelix Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Vionelix Pharmaceuticals
Compare insights from companies similar to Vionelix Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vionelix Pharmaceuticals
$5.2M
11-50
Private
-
2021
N/A
Company Profile Activity
Activity Insights
Vionelix Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vionelix Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vionelix Pharmaceuticals.
Vionelix Pharmaceuticals Tech Stack
A closer look at the technologies used by Vionelix Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Vionelix Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Vionelix Pharmaceuticals, Inc. is an early-stage Anglo-American biotech company focused on revolutionizing antiviral therapies through its proprietary RAPTOR-AI platform. The company develops direct-acting antiviral drugs designed to be effective against treatment-resistant infections and rapidly mutating pathogens, targeting diseases such as hepat... Read More
